Selected article for: "specificity sensitivity and spike protein"

Author: Rahmati, Zeinab; Roushani, Mahmoud; Hosseini, Hadi; Choobin, Hamzeh
Title: An electrochemical immunosensor using SARS-CoV-2 spike protein-nickel hydroxide nanoparticles bio-conjugate modified SPCE for ultrasensitive detection of SARS‐CoV‐2 antibodies
  • Cord-id: 1ym09u9d
  • Document date: 2021_8_6
  • ID: 1ym09u9d
    Snippet: As a promising approach for serological tests, the present study aimed at designing a robust electrochemical biosensor for selective and quantitative analysis of SARS‐CoV‐2-specific viral antibodies. In our proposed strategy, recombinant SARS-CoV-2 spike protein antigen (spike protein) was used as a specific receptor to detect SARS‐CoV‐2-specific viral antibodies. In this sense, with a layer of nickel hydroxide nanoparticles (Ni(OH)(2) NPs), the screen-printed carbon electrode (SPCE) sur
    Document: As a promising approach for serological tests, the present study aimed at designing a robust electrochemical biosensor for selective and quantitative analysis of SARS‐CoV‐2-specific viral antibodies. In our proposed strategy, recombinant SARS-CoV-2 spike protein antigen (spike protein) was used as a specific receptor to detect SARS‐CoV‐2-specific viral antibodies. In this sense, with a layer of nickel hydroxide nanoparticles (Ni(OH)(2) NPs), the screen-printed carbon electrode (SPCE) surface was directly electrodeposited to ensure better loading of spike protein on the surface of SPCE. The differential pulse voltammetry (DPV) showed signals which were inversely proportional to the concentrations of the antibody (from 1 fg mL(−1) L to 1 µg mL(−1)) via a specific and stable binding reaction. The assay was performed in 20 min with a low detection limit of 0.3 fg mL(−1). This biodevice had high sensitivity and specificity as compared to non-specific antibodies. Moreover, it can be regarded as a highly sensitive immunological diagnostic method for SARS‐CoV‐2 antibody in which no labeling is required. The fabricated hand-held biodevice showed an average satisfactory recovery rate of ∼99-103% for the determination of antibodies in real blood serum samples with the possibility of being widely used in individual serological qualitative monitoring. Also, the biodevice was tested using real patients and healthy people samples, where the results are already confirmed using the enzyme-linked immunosorbent assay (ELISA) procedure, and showed satisfactory results.

    Search related documents:
    Co phrase search for related documents
    • acetate buffer and acute respiratory syndrome coronavirus: 1
    • acetate buffer and acute sars cov respiratory syndrome coronavirus: 1
    • acetic acid and active site: 1, 2
    • active infection and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active infection and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active infection and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active infection and addition method: 1
    • active infection detect and acute respiratory syndrome: 1, 2
    • active infection detect and acute respiratory syndrome coronavirus: 1, 2
    • active infection detect and acute sars cov respiratory syndrome coronavirus: 1, 2
    • active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and addition method: 1
    • active site and local hospital: 1
    • acute respiratory syndrome and addition method: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory syndrome and local hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome coronavirus and addition method: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome coronavirus and local hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22